Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (144)

« Back to Publications

Timing for Starting Antiseizure Medication Withdrawal After Epilepsy Surgery in Adults.

Ferreira-Atuesta C. et al, (2026), Neurology, 106

Clock gene dysregulation in epilepsy: A systematic review.

Fernandes-Campos G. et al, (2026), Epilepsia Open, 11, 53 - 77

Dermato-neuro syndrome triggered by SARS-CoV-2 vaccination.

Liem B. et al, (2026), Pract Neurol, 26, 51 - 54

Is resective surgery cost-effective for adults with epilepsy? A cost-utility analysis in a publicly funded healthcare system.

Bonnon A. et al, (2025), J Neurol Neurosurg Psychiatry, 97, 25 - 32

Hypophosphatemia in suspected seizures evaluated in first seizure clinics and neurology consults.

Binks SNM. et al, (2025), Epilepsia Open, 10, 2025 - 2031

Epilepsy and mental health disorders: current challenges and potential solutions

De Giorgi R. et al, (2025), The British Journal of Psychiatry, 1 - 8

Epilepsy Research Institute UK Sudden Unexpected Death in Epilepsy (SUDEP) workshop: Identifying the pre-clinical and clinical priorities for SUDEP research.

Pickard H. et al, (2025), Epilepsy Behav, 171

"The traditional healer said, 'I had a genie that scared me in my eyes, and that is why I fall": An ethnographic study in Mahenge, Tanzania.

Magili PF. et al, (2025), Epilepsy Behav, 170

Effect of levetiracetam on cognition in patients with cognitive decline: A systematic review and meta-analysis of randomized controlled trials.

Faini C. et al, (2025), Epilepsia Open, 10, 1253 - 1259

Classification of the epilepsies: evolving with time, science and knowledge.

Sen A. and Zuberi SM., (2025), Pract Neurol, 25, 298 - 299

Epilepsy in low- to middle-income countries.

Sen A. et al, (2025), Curr Opin Neurol, 38, 121 - 127

Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trial.

Sen A. et al, (2024), Epilepsia Open, 9, 2353 - 2364

Equitable access to levetiracetam for people with epilepsy.

Sen A. et al, (2024), Lancet Neurol, 23, 1076 - 1077

The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study.

Vasey MJ. et al, (2024), Epilepsia Open, 9, 1931 - 1947

Baseline characteristics and predictors for early implantation of vagus nerve stimulation therapy in people with drug-resistant epilepsy: Observations from an international prospective outcomes registry (CORE-VNS).

Kwan P. et al, (2024), Epilepsia Open, 9, 1837 - 1846

Load More

1
2
3
4
5
6
7
...
»